$0.365
-0.151 (-29.25%)
At Close: Jun 09, 2026
Initial 60-Store California Entry Extends XXII's Reduced-Nicotine Rollout Into One of the Nation's Largest and Most Influential Tobacco Markets, With a Pathway to Broader Expansion MOCKSVILLE, N.C.,
22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers
09:00am, Monday, 18'th May 2026
New Product Introduction Broadens XXII's Fast-Scaling Pinnacle Brand Reinforcing Brand Power, Opening New Retail Doors, and Strengthening the Company's Revenue and Margin Expansion Story MOCKSVILLE
VLN® Product Launch in Over 150 New High-Visibility Store Locations Positions XXII to Introduce VLN® to New Consumers and Potentially Capture a Large Adult-Smoker Market, Accelerate High-Ma
22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review
01:50pm, Tuesday, 12'th May 2026
FDA filing covers renewal applications for VLN® King and VLN® Menthol King, the first combusted cigarettes authorized as Modified Risk Tobacco Products, as 22nd Century advances its regulatory pathw
22nd Century Group, Inc. (XXII) Q1 2026 Earnings Call Prepared Remarks Transcript
12:51pm, Saturday, 09'th May 2026
22nd Century Group, Inc. (XXII) Q1 2026 Earnings Call Prepared Remarks Transcript
22nd Century Group Reports First Quarter 2026 Financial Results
06:00am, Thursday, 07'th May 2026
Continues VLN ® Commercial Expansion with New Stores Selling Proprietary Branded VLN ® Products
22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026
09:00am, Monday, 04'th May 2026
MOCKSVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harm
22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership
04:35pm, Wednesday, 29'th Apr 2026
Chairman & CEO Larry Firestone Details 2026 Priorities and Shareholder Value Strategy MOCKSVILLE, N.C., April 29, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco pro
22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University
07:50am, Thursday, 23'rd Apr 2026
MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporat
Company to Pursue Additional PMTA Submissions, Building on Its Status as the Only Holder of an FDA-Authorized Low Nicotine Combustible Cigarette Branded as VLN ® Products Expanded PMTA Portfolio and
22nd Century Group, Inc. (XXII) Q4 2025 Earnings Call Prepared Remarks Transcript
10:05am, Thursday, 26'th Mar 2026
22nd Century Group, Inc. (XXII) Q4 2025 Earnings Call Prepared Remarks Transcript
22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results
06:00am, Thursday, 26'th Mar 2026
VLN ® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN ® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduct
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026
08:00am, Monday, 23'rd Mar 2026
MOCKSVILLE, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the ha
22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products
05:07pm, Monday, 23'rd Feb 2026
Expansion in 2026 Forecasted to Exceed 5,000 Retail Outlets Nationwide as Consumers Demonstrate Interest in VLN ® Brands
22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results
04:15pm, Friday, 20'th Feb 2026
Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN ® commercial expansion drives shift toward higher margin proprietary branded pr
Sign In
Buy XXII